학술논문

Adding venetoclax to lenalidomide and rituximab is safe and effective in patients with untreated mantle cell lymphoma
Document Type
Article
Source
In: Blood Advances. (Blood Advances, 16 August 2023, 7(16):4518-4527)
Subject
Language
English
ISSN
24739537
24739529